Evidence map›Paper›PMID 36525488›Full record

ArticleScience advances2022

Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms.

Angela Cappello, Mara Mancini, Stefania Madonna, Serena Rinaldo, Alessio Paone, Claudia Scarponi, Antonio Belardo, Lello Zolla, Alessandro Zuccotti, Emanuele Panatta and 8 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. A PSAT1 buff of YBX1 transcriptionally sustains HLA-E-mediated evasion of NK immunity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. B cell-derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor-mediated signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Targeting one-carbon metabolism for cancer immunotherapy.Clinical and translational medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Angela CappelloDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-0893-445X
Mara ManciniIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0001-5173-4854
Stefania MadonnaIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0003-0585-6783
Serena RinaldoDepartment of Biochemical Sciences A.Rossi Fanelli, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-0682-023X
Alessio PaoneDepartment of Biochemical Sciences A.Rossi Fanelli, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-9406-3982
Claudia ScarponiIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.
Antonio BelardoAgriculture and Forest Sciences (DAFNE), University of Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-3128-3598
Lello ZollaAgriculture and Forest Sciences (DAFNE), University of Tuscia, 01100 Viterbo, Italy.
Alessandro ZuccottiIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0001-5581-7980
Emanuele PanattaDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-8723-9564
Sabatino PallottaIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.
Margherita Annicchiarico-PetruzzelliIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-4717-4740
Cristina AlbanesiIstituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-7537-6833
Francesca CutruzzolàDepartment of Biochemical Sciences A.Rossi Fanelli, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-4621-2135
Lu WangChinese Medicine and Systems Biology/School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.ORCID 0000-0002-3918-3399
Wei JiaChinese Medicine and Systems Biology/School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.ORCID 0000-0002-3739-8994
Gerry MelinoDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Eleonora CandiDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-8332-4825
Istituto Dermopatico dell'Immacolata · ITUniversity of Rome Tor Vergata · ITSapienza University of Rome · ITHong Kong Baptist University · HKUniversità degli Studi della Tuscia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of nutrient availability to control epidermal cell proliferation, inflammation, and hyperproliferative diseases remains unknown. Here, we studied extracellular serine and serine/glycine metabolism using human keratinocytes, human skin biopsies, and a mouse model of psoriasis-like disease. We focused on a metabolic enzyme, serine hydroxymethyltransferase (SHMT), that converts serine into glycine and tetrahydrofolate-bound one‑carbon units to support cell growth. We found that keratinocytes are both serine and glycine auxotrophs. Metabolomic profiling and hypoxanthine supplementation indicated that SHMT silencing/inhibition reduced cell growth through purine depletion, leading to nucleotide loss. In addition, topical application of an SHMT inhibitor suppressed both keratinocyte proliferation and inflammation in the imiquimod model and resulted in a decrease in psoriasis-associated gene expression. In conclusion, our study highlights SHMT2 activity and serine/glycine availability as an important metabolic hub controlling both keratinocyte proliferation and inflammatory cell expansion in psoriasis and holds promise for additional approaches to treat skin diseases.

Indexed as

PsoriasisSkin DiseasesAnimalsCell ProliferationGlycineGlycine HydroxymethyltransferaseHumansInflammationMiceSerineGlycineGlycine HydroxymethyltransferaseSerine

Identifiers

PMID36525488
PMCPMC12794945
OpenAlexW4312019433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.